Skip to main content

RT @DrMiniDey: Safety update for #filgotinib in #RA over ~2.2yrs treatment 👉🏼Well-tolerated with no ne safety conc

Social Author Name
Mrinalini Dey
Tweet Content
Safety update for #filgotinib in #RA over ~2.2yrs treatment 👉🏼Well-tolerated with no ne safety concerns since 2020 👉🏼AE incidence rates decreased or remained stable 👉🏼Slight incr rates of NMSC & non-NMSC malignancies Abs#1698 #ACR21 @RheumNow https://t.co/0jbZFVgiyN https://t.co/yOlntLwQlU
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×